Dual HER2 blockade with trastuzumab and lapatinib yielded good response rates in HER2-amplified, RAS wild type, treatment-refractory metastatic colorectal cancer patients, according to results of the HERACLES study.
This video examines current research on the use of vaccines in low-grade glioma for the prevention of high-grade disease.
This video examines a study that used liquid biopsies to monitor disease progression in patients with bladder cancer.
This video reviews the latest trials and research on immunotherapeutic agents being tested in breast cancer.
A nivolumab/ipilimumab combination significantly improved overall survival for advanced melanoma patients.
This video highlights a novel scoring system using microRNA signatures that predicted poor overall survival and bone metastasis in patients with luminal A breast cancer.
This video examines how a specific combination of KIR/KIR-ligand genotypes in high-risk neuroblastoma patients may be predictive of outcomes when adding dinutuximab to isotretinoin.
In this interview we discuss long-term data on the anti–PD-L1 immunotherapy atezolizumab in metastatic triple-negative breast cancer.
This video reviews results of the ZUMA-1 trial, which tested the CAR T-cell therapy axicabtagene ciloleucel in patients with advanced non-Hodgkin lymphoma.
This video examines results of a study that found that shorter sleep duration was linked with an increased risk of death among patients with prostate cancer.